Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tefibazumab, a humanized IgG1κ monoclonal antibody, targets and binds to clumping factor A, an adhesion protein expressed on the surface of Staphylococcus aureus, and is under investigation for the treatment of serious Staphylococcus aureus infections [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Tefibazumab, a humanized IgG1κ monoclonal antibody, targets and binds to clumping factor A, an adhesion protein expressed on the surface of Staphylococcus aureus, and is under investigation for the treatment of serious Staphylococcus aureus infections [1] [2]. |
In vitro | Tefibazumab features an antigen-binding region composed of variable amino acid sequences from human (>98%) and murine (<2%) origins. |
Alias | INH-H 2002 |
Cas No. | 521079-87-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.